Managing Director Hidetoshi Segi To Become President And COO Pending Approval At Shareholders Meeting In June

Rohto Pharmaceutical

09/05/2025 04:37

May 9 (Reuters) - Rohto Pharmaceutical Co Ltd 4527.T:

ROHTO PHARMACEUTICAL CO LTD - MANAGING DIRECTOR HIDETOSHI SEGI TO BECOME PRESIDENT AND COO PENDING APPROVAL AT SHAREHOLDERS MEETING IN JUNE

Further company coverage: 4527.T